AstraZeneca Is Said to Have Explored Bristol Myers Merger
Bloomberg's Michelle Davis joins Dani Burger on "Bloomberg Deals." AstraZeneca has explored an acquisition of Bristol-Myers Squibb, according to people familiar with the matter, in a potential megadeal that would rank as the largest ever in pharma. (Source: Bloomberg)
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.